60 Results for "

UCB L059-d3

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "UCB L059-d3" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-133122
CAS No.: 1515888-53-5
Purity:  98.38%
Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology Cancer

UCB-9260, an orally active compound, inhibits TNF signaling by stabilising an asymmetric form of the trimer. UCB-9260 is selective for TNF over other superfamily members, and binds TNF with a similar Kd of 13 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0106
CAS No.: 102767-28-2
Synonyms: UCB L059
Target:  

DNA Methyltransferase

Research Areas:  

Neurological Disease Cancer

Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109009
CAS No.: 1294000-61-5
Purity:  99.65%
Synonyms: UCB-0942
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Padsevonil (UCB0942) is a potent antiepileptic agent that selectively acts on presynaptic and postsynaptic targets. Padsevonil binds to synaptic vesicular protein 2 (SV2) with high affinity. Padsevonil is also a positive allosteric modulator and partial agonist of GABAAR, with high potency against α1 and α5 receptors. Padsevonil has antiepileptic effects in a variety of rodent models .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16754
CAS No.: 1362850-20-1
Synonyms: UCB5857
Target:  

PI3K

Research Areas:  

Inflammation/Immunology

Seletalisib (UCB5857) is potent and selective PI3Kδ inhibitor with an IC50 of 12 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99280
CAS No.: 1418205-77-2
Synonyms: CDP4940; UCB-4940

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0585
CAS No.: 7491-74-9
Synonyms: UCB-6215
Target:  

iGluR

Research Areas:  

Neurological Disease

Piracetam (UCB-6215) is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9979
CAS No.: 1584645-37-3
Synonyms: UCB7665

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112613
CAS No.: 1616413-96-7
Purity:  99.59%
Target:  

PI4K

Research Areas:  

Inflammation/Immunology

UCB9608 is a potent, selective and orally active PI4KIIIβ inhibitor, with an IC50 of 11 nM, selective over PI3KC2 α, β, and γ lipid kinases. UCB9608 improves metabolic stability and exhibits excellent pharmacokinetic profile, acts as a potent immunosuppressive agent .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119810
CAS No.: 357336-74-4
Purity:  99.73%
Synonyms: UCB 44212
Research Areas:  

Neurological Disease

Seletracetam (Ucb 44212), as an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-A0075
CAS No.: 13073-96-6
Synonyms: UCB 1402 dihydrochloride; NSC289116 dihydrochloride
Research Areas:  

Inflammation/Immunology

Decloxizine (UCB-1402; NSC289116) dihydrochloride is an orally active bronchodilator that can penetrate the blood-brain barrier. Decloxizine dihydrochloride is a piperazine-type H1 histamine receptor antagonist. Decloxizine dihydrochloride selectively blocks H1 histamine receptors, inhibiting histamine-induced capillary dilation, edema, and itching. Decloxizine dihydrochloride has some 5-HT2 receptor antagonistic activity. Decloxizine dihydrochloride can be used in studies of urticaria, allergic rhinitis, and bronchial asthma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-17582
CAS No.: 3733-63-9
Synonyms: UCB-1402; NSC289116
Research Areas:  

Inflammation/Immunology

Decloxizine (UCB-1402; NSC289116) is an orally active bronchodilator that can penetrate the blood-brain barrier. Decloxizine is a piperazine-type H1 histamine receptor antagonist. Decloxizine selectively blocks H1 histamine receptors, inhibiting histamine-induced capillary dilation, edema, and itching. Decloxizine has some 5-HT2 receptor antagonistic activity. Decloxizine can be used in studies of urticaria, allergic rhinitis, and bronchial asthma .
loading...
    loading...
Cat. No.: HY-P99643
CAS No.: 2390147-17-6
Synonyms: UCB6114

Target:  

Dan family

Research Areas:  

Cancer

Ginisortamab (UCB6114) is a fully human IgG4P anti Gremlin-1 monoclonal antibody, with mean IC50 values of 8.2 nM and 9 nM against human and mouse gremlin-1, respectivly. Ginisortamab inhibits gremlin-1 antagonism of BMP signaling pathways. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors .
loading...
    loading...
Cat. No.: HY-P99471
CAS No.: 2244960-75-4
Synonyms: UCB 0107

Target:  

Tau Protein

Research Areas:  

Neurological Disease

Bepranemab is a humanized IgG4 monoclonal antibody that binds to the central region of tau protein. Bepranemab inhibits the seeding, aggregation of pathological tau protein and the spread of tau pathology to distal brain regions. Bepranemab is applicable to research related to Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-156454
CAS No.: 637324-45-9
Purity:  98.49%
Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

UCB-6876 is a TNFα inhibitor. UCB-6876 specifically binds to the asymmetric crystalline form of TNF-α trimer with a KD of 22 μM. UCB-6876 is applicable to research related to autoimmune diseases (rheumatoid arthritis and Crohn's disease) .
loading...
    loading...
Cat. No.: HY-B0106A
CAS No.: 33996-58-6
Synonyms: UCB 6474
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Etiracetam is a racetam-class nootropic agent. Etiracetam enhances learning and memory in both normal and amnesic rats. Etiracetam can be used in studies related to memory retrieval disorders and amnesic diseases such as Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-P990735
CAS No.: 2765066-99-5
Synonyms: UCB-1381

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Donzakimig is a trispecific anti-IL-13/IL-22/HSA antibody. Donzakimig adopts a Fab-scFv-scFv structural format (without an Fc region), in which the Fab domain is linked to the scFv domains via a S (G4S)2 linker. Donzakimig binds to and inhibits the activities of IL-13 and IL-22, thereby blocking the signal transduction of these two cytokines. Donzakimig can extend its serum half-life by binding to human serum albumin, enhancing its in vivo stability and achieving long-acting efficacy. Donzakimig can be used in research on moderate-to-severe atopic dermatitis, moderate-to-severe asthma (especially eosinophilic type), psoriasis, inflammatory bowel disease, and other conditions .
loading...
    loading...
Cat. No.: HY-P99512
CAS No.: 2098280-42-1
Synonyms: UCB-7858

Target:  

Glutaminase

Research Areas:  

Endocrinology

Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab inhibits TG2 crosslinking transamidation activity with an IC50 of 0.25 nM and a Kd of <50 pM. Zampilimab improves renal fibrosis .
loading...
    loading...
Cat. No.: HY-145580
CAS No.: 1802518-92-8
Purity:  98.60%
Synonyms: UCB0599; (R)-NPT200-11
Target:  

α-synuclein

Research Areas:  

Neurological Disease

Minzasolmin (UCB0599; (R)-NPT200-11) is an orally active, blood-brain-permeable α-synuclein (α-Syn) inhibitor that selectively binds to α-Syn misfolded intermediates (such as oligomers) and inhibits aggregation and fibril formation by regulating their conformational stability. Minzasolmin can reduce the generation of pathological oligomers and block neurotoxic signaling, thereby reducing the abnormal accumulation of α-Syn in the brain. Minzasolmin significantly improved motor deficits, reduced neuroinflammatory markers, and α-Syn-related pathological deposition in transgenic mouse models .
loading...
    loading...
Cat. No.: HY-75385
CAS No.: 455264-30-9
Synonyms: CDP323; UCB1184197
Target:  

Integrin

Research Areas:  

Inflammation/Immunology

Zaurategrast ethyl ester (CDP323), the ethyl ester proagent of CT7758 , is a α4β1/α4β7 integrin antagonist used for the treatment of inflammatory and autoimmune disorders .
loading...
    loading...
Cat. No.: HY-147045
CAS No.: 1515887-44-1
Purity:  97.09%
Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

UCB-5307 is a potent TNF signaling inhibitor with a KD of 9 nM for human TNFα. UCB-5307 can penetrate the preformed hTNF/hTNFR1 complex .
loading...
    loading...